MicroRNA-320а as a novel biomarker at preclinical stage of necrotizing enterocolitis in term neonates with congenital heart defects
Our study demonstrates, for the first time, that plasma miR-320a-3p levels can be used as a preclinical biomarker for NEC in term newborns with CHD.
Authors
- Aleksandra Kaplina (ORCID: https://orcid.org/0000-0001-6939-6961)
- Anna Aleksandrovna Kostareva (ORCID: https://orcid.org/0000-0002-9349-6257)
- А. С. Головкин (ORCID: https://orcid.org/0000-0002-7577-628X)
- Ekaterina Zaikova (ORCID: https://orcid.org/0000-0003-0584-2330)
- Т. М. Первунина (ORCID: https://orcid.org/0000-0001-9948-7303)
- N. Petrova (ORCID: https://orcid.org/0000-0003-3523-3296)
- Olga V. Kalinina (ORCID: https://orcid.org/0000-0002-9445-477X)
Institutions
- Federal Almazov North-West Medical Research Centre (RU)
Publication Details
- Journal
- World Journal of Clinical Pediatrics
- Published
- 2025-06-16
- DOI
- https://doi.org/10.5409/wjcp.v14.i3.103652
- Primary Topic
- Infant Nutrition and Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00